Key result
Review outlines optimal antiplatelet strategies for unstable angina and non-ST elevation ACS.
Why the study?
What is the optimal strategy for using antiplatelet agents (aspirin, clopidogrel, glycoprotein IIb/IIIa antagonists) in patients with unstable angina?
Population
Patients with non-ST elevation acute coronary syndrome (unstable angina)
Design
Review
Authors
Loading...
This review provides a strategic framework for the use of various antiplatelet agents in the management of unstable angina.
What is the optimal strategy for using antiplatelet agents (aspirin, clopidogrel, glycoprotein IIb/IIIa antagonists) in patients with unstable angina?
This review provides a strategic framework for the use of various antiplatelet agents in the management of unstable angina.
Scott A. Harding (2002) studied this question. Antiplatelet agents are reviewed to present a clinical strategy for their use in patients with unstable angina and non-ST elevation acute coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: